[LXRX] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -8.87%
YoY- -7.17%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 27,717 566 419 238 372 355 781 81.18%
PBT -36,015 -35,282 -40,498 -31,658 -29,539 -26,103 -27,539 4.56%
Tax 1,135 1,627 205 503 -576 560 -26 -
NP -36,015 -35,282 -40,498 -31,658 -29,539 -26,103 -27,513 4.58%
Tax Rate - - - - - - - -
Total Cost 63,732 35,848 40,917 31,896 29,911 26,458 28,294 14.47%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -129.94 -6,233.57 -9,665.39 -13,301.68 -7,940.59 -7,352.96 -3,522.79 -42.27%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -0.35 -0.34 -0.55 -0.43 -0.42 -0.54 -0.57 -7.79%
EPS Diluted -0.35 -0.34 -0.55 -0.43 -0.42 -0.54 -0.57 -7.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.